ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMGastos comerciales, generales y administrativos1.37 B948.1 M928.7 M886.6 M1.03 B928.8 M3.77 BInvestigación y desarrollo—222 M218.8 M250.4 M—248.6 M—Beneficio operativo-179.8 M-2.88 B233 M178.8 M-192.7 M-79.7 M139.4 MTotal de ingresos no operativos-226.5 M-99.3 M-333.5 M-67.1 M-30.7 M-47.5 M-478.8 MGastos por intereses, netos de intereses capitalizados120.2 M115.5 M116.6 M119.6 M119.6 M120.1 M475.9 MIngresos no operativos, una vez deducidos los gastos por intereses-120.2 M-115.5 M-116.6 M-119.6 M-119.6 M-120.1 M-475.9 MIngresos/gastos extraordinarios-226.5 M-99.3 M-333.5 M-67.1 M-30.7 M-47.5 M-478.8 MBeneficio antes de impuestos-526.5 M-3.1 B-217.1 M-7.9 M-343 M-247.3 M-815.3 MParticipación en los beneficios———————Impuestos-10 M-55 M-212.5 M120.3 M-2.9 M-423.7 M-518.8 MParticipación minoritaria———————Otros ingresos/gastos después de impuestos-478.3 M-203.8 M-522.5 M-109.5 M-133.5 M-182.3 M-947.8 MBeneficio neto antes de actividades interrumpidas-516.5 M-3.04 B-4.6 M-128.2 M-340.1 M176.4 M-296.5 MOperaciones suspendidas———————Beneficio neto-516.5 M-3.04 B-4.6 M-128.2 M-340.1 M176.4 M-296.5 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas-516.5 M-3.04 B-4.6 M-128.2 M-340.1 M176.4 M-296.5 MBeneficio básico por acción-0.44-2.550-0.11-0.340.15-0.3Beneficio por acción diluido-0.43-2.550-0.11-0.340.15-0.3Número medio de acciones ordinarias1.21 B1.19 B1.17 B1.16 B1.2 B1.16 B—Acciones diluidas01.19 B1.17 B1.16 B01.18 B—EBITDA566.4 M-2.22 B911.3 M867.3 M574.1 M596.4 M2.95 BEBIT-179.8 M-2.88 B233 M178.8 M-192.7 M-79.7 M139.4 MCosto de los ingresos2.31 B2.09 B2.25 B2.39 B2.56 B2.36 B9.55 BOtros costes de producción———————Amortización y depreciación (flujo de caja)746.2 M664.7 M678.3 M688.5 M766.8 M676.1 M2.81 B
Viatris Inc. - Common Stock
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community.
Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.